BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Feb 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-02-01

Reporting Person: Davis George Eric (EVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-01	Common Stock	M	30000	$38.59	Acquired	112942	Direct
2018-02-01	Common Stock	S	30000	$90.6555	Disposed	82942	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Stock Option (Right to buy Common Stock)	$38.59	M	30000	Disposed	2018-05-21	Common Stock (30000)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

F2: The price in column 4 is the weighted average price. The price actually received ranged from $90.00 to $91.86. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.